The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy

Melanoma Clinical Trial

Official title:

The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00237965
• Other study ID #: 00001402
• Status: Completed
• Phase: N/A
• First received: October 11, 2005
• Last updated: October 11, 2005

Study information

• Verified date: May 2004
• Source: Brown University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

This study aims to improve Skin Self-Examination accuracy by a simple cost effective intervention requiring participants to complete a mole-mapping diagram.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male and female subjects above age 18 of any ethnicity will be enrolled in this study.

Exclusion Criteria:

• Subjects will be excluded from the study if they have significant skin disease which would not allow manipulation of their photographs consistent with the rest of the subjects.

• Since the study instructions are in English, Non-English speakers will be excluded.

• Those with co-morbidity sufficiently severe to prevent them from being able to perform a SSE will be excluded.

• In addition, those with cognitive impairment who are unable to give informed consent, or to understand the study instructions given to them, will be excluded.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind

Related Conditions & MeSH terms

• Melanoma

Intervention

Behavioral:
• Mole Mapping Diagram

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Brown University